126 novel mutations in Italian patients with neurofibromatosis type 1

By  

Molecular Genetics & Genomic Medicine, Vol. 3, Iss. 6, 2015-11 ,pp. : 513-525

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1 (NF1)

By Wittinghofer A.  

Human Molecular Genetics, Vol. 7, Iss. 8, 1998-08 ,pp. : 1261-1268

Oxford University Press

Access to resources Recommend Favorite

Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells

By Li Fang   Munchhof Amy M.   White Hilary A.   Mead Laura E.   Krier Theresa R.   Fenoglio Amy   Chen Shi   Wu Xiaohua   Cai Shanbao   Yang Feng-Chun   Ingram David A.  

Human Molecular Genetics, Vol. 15, Iss. 11, 2006-06 ,pp. : 1921-1930

Oxford University Press

Access to resources Recommend Favorite

Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between -agonist and corticosteroid pathways

By Tantisira Kelan G.  

Human Molecular Genetics, Vol. 14, Iss. 12, 2005-06 ,pp. : 1671-1677

Oxford University Press

Access to resources Recommend Favorite

Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1

By Ars Elisabet   Serra Eduard   García Judit   Kruyer Helena   Gaona Antonia   Lázaro Conxi   Estivill Xavier  

Human Molecular Genetics, Vol. 9, Iss. 2, 2000-01 ,pp. : 237-247

Oxford University Press

Access to resources Recommend Favorite